Aggressive regimen reduces mortality in drug-resistant TB
(Medical Xpress)—Aggressive drug regimens used to treat multidrug-resistant tuberculosis reduce the risk of death by about 40 percent when they include at least five drugs likely to be effective against ...
Diseases, Conditions, Syndromes
Mar 15, 2013 |
not rated yet |
0
|
New tuberculosis vaccine doesn't protect infants, study finds
The world's most advanced tuberculosis vaccine failed to protect babies against the infectious disease, according to a new study in South Africa.
Diseases, Conditions, Syndromes
Feb 04, 2013 |
not rated yet |
0
Tuberculosis: WHO-endorsed test offers rapid detection
A diagnostic test for tuberculosis (TB) can accurately and quickly detect both TB and drug-resistant strains, according to a new study. The authors of a new systematic review assessing the diagnostic accuracy of the Xpert® ...
Diseases, Conditions, Syndromes
Jan 30, 2013 |
not rated yet |
0
Antibiotics based on a new principle may defeat MRSA
(Medical Xpress)—Scientists at Karolinska Institutet in Sweden have presented a new principle for fighting bacterial infections, in other words, a new type of antibiotic, in the FASEB Journal. The new antibiotic mechan ...
Medical research
Dec 18, 2012 |
5 / 5 (6) |
0
|
Scientists: Novel TB drug combo passes first test
Scientists are hot on the trail of a new tuberculosis treatment that a small study suggests might one day offer an alternative to battle this deadly lung disease, even if it is resistant to today's two main drugs.
Diseases, Conditions, Syndromes
Jul 23, 2012 |
not rated yet |
0
Trial signals major milestone in hunt for new TB drugs
A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two ...
Diseases, Conditions, Syndromes
Jul 23, 2012 |
not rated yet |
0
Millions of diabetics could die of tuberculosis
A third of the world's human population is infected with a dormant tuberculosis bacteria, primarily people living in developing countries. The bacteria presents a lifelong TB risk. Recent research out of the University of ...
Diabetes
Jul 09, 2012 |
not rated yet |
0
New medicine might fight drug-resistant TB, study says
(HealthDay) -- More than four decades after the last introduction of fresh treatments for tuberculosis, a new medication for multidrug-resistant strains of the global scourge has shown promise in a multinational ...
Diseases, Conditions, Syndromes
Jun 06, 2012 |
5 / 5 (1) |
0
|
Growing presence of drug-resistant tuberculosis fuels need for faster development of new combination therapies
Johns Hopkins experts in the prevention and treatment of multidrug-resistant tuberculosis are calling for increased screening and more rapid testing of the 9 million people worldwide estimated to be infected each year with ...
Diseases, Conditions, Syndromes
Jun 06, 2012 |
not rated yet |
0
|
Old antibiotic could be a new weapon to fight tuberculosis
(Medical Xpress) -- A cheap and safe antibiotic that is widely available in the developing world might have a new use as a tuberculosis (TB) treatment, according to new research.
Diseases, Conditions, Syndromes
Feb 20, 2012 |
5 / 5 (1) |
1
|
Researchers validate preclinical effectiveness of TB drug target
In research at SRI International, scientists evaluating new drug targets against tuberculosis (TB) recently validated the preclinical effectiveness of a target that could rapidly eliminate infections and potentially shorten ...
Diseases, Conditions, Syndromes
Nov 29, 2011 |
not rated yet |
0
Tuberculosis bacterium's outer cell wall disarms the body's defense to remain infectious
The bacterium that causes tuberculosis has a unique molecule on its outer cell surface that blocks a key part of the body's defense. New research suggests this represents a novel mechanism in the microbe's evolving efforts ...
Diseases, Conditions, Syndromes
Oct 03, 2011 |
5 / 5 (3) |
0
|
Scientists explain unique activity of TB drug pyrazinamide
Pyrazinamide has been used in combination with other drugs as a first-line treatment for people with tuberculosis (TB) since the 1950s, but exactly how the drug works has not been well understood.
Medical research
Aug 11, 2011 |
not rated yet |
0
|
